Literature DB >> 21075649

The response to valve injury. A paradigm to understand the pathogenesis of heart valve disease.

Chen Li1, Songyi Xu, Avrum I Gotlieb.   

Abstract

Human heart valve diseases have become an important topic in cardiovascular pathology and medicine. These diseases have different etiologies and manifestations. However, the most common ones including calcific aortic stenosis have histopathological features that are best characterized as a "response to tissue injury" similar to ones seen in numerous tissues and organs. The valve interstitial cell is the prevalent cell type in the valve and is likely the master cell which ultimately regulates cell and molecular repair processes within the valve that involve autocrine and paracrine processes as well as interactions with the matrix components of the valve. This presentation explores the concept of "response to tissue injury" in understanding the pathogenesis of calcific aortic stenosis.
Copyright © 2011. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2010        PMID: 21075649     DOI: 10.1016/j.carpath.2010.09.008

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  16 in total

1.  Recruitment of bone marrow-derived valve interstitial cells is a normal homeostatic process.

Authors:  Zoltan Hajdu; Stephen J Romeo; Paul A Fleming; Roger R Markwald; Richard P Visconti; Christopher J Drake
Journal:  J Mol Cell Cardiol       Date:  2011-08-16       Impact factor: 5.000

2.  Differential activation of valvulogenic, chondrogenic, and osteogenic pathways in mouse models of myxomatous and calcific aortic valve disease.

Authors:  Jonathan D Cheek; Elaine E Wirrig; Christina M Alfieri; Jeanne F James; Katherine E Yutzey
Journal:  J Mol Cell Cardiol       Date:  2012-01-10       Impact factor: 5.000

3.  Loss of β-catenin promotes chondrogenic differentiation of aortic valve interstitial cells.

Authors:  Ming Fang; Christina M Alfieri; Alexia Hulin; Simon J Conway; Katherine E Yutzey
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-10-23       Impact factor: 8.311

Review 4.  Genetic predisposition to calcific aortic stenosis and mitral annular calcification.

Authors:  Anton G Kutikhin; Arseniy E Yuzhalin; Elena B Brusina; Anastasia V Ponasenko; Alexey S Golovkin; Olga L Barbarash
Journal:  Mol Biol Rep       Date:  2014-06-06       Impact factor: 2.316

5.  Transforming growth factor-β regulates the growth of valve interstitial cells in vitro.

Authors:  Chen Li; Avrum I Gotlieb
Journal:  Am J Pathol       Date:  2011-08-16       Impact factor: 4.307

6.  Biglycan induces the expression of osteogenic factors in human aortic valve interstitial cells via Toll-like receptor-2.

Authors:  Rui Song; Qingchun Zeng; Lihua Ao; Jessica A Yu; Joseph C Cleveland; Ke-Seng Zhao; David A Fullerton; Xianzhong Meng
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-09-13       Impact factor: 8.311

7.  Extracellular matrix remodeling in wound healing of critical size defects in the mitral valve leaflet.

Authors:  Elizabeth H Stephens; Tom C Nguyen; Jack G Blazejewski; Dragoslava P Vekilov; Jennifer P Connell; Akinobu Itoh; Neil B Ingels; D Craig Miller; K Jane Grande-Allen
Journal:  Heart Vessels       Date:  2015-11-12       Impact factor: 2.037

Review 8.  Inflammatory and Biomechanical Drivers of Endothelial-Interstitial Interactions in Calcific Aortic Valve Disease.

Authors:  Katherine Driscoll; Alexander D Cruz; Jonathan T Butcher
Journal:  Circ Res       Date:  2021-04-29       Impact factor: 17.367

9.  Sex-related differences in gene expression by porcine aortic valvular interstitial cells.

Authors:  Chloe M McCoy; Dylan Q Nicholas; Kristyn S Masters
Journal:  PLoS One       Date:  2012-07-10       Impact factor: 3.240

10.  TGF-β mediates early angiogenesis and latent fibrosis in an Emilin1-deficient mouse model of aortic valve disease.

Authors:  Charu Munjal; Amy M Opoka; Hanna Osinska; Jeanne F James; Giorgio M Bressan; Robert B Hinton
Journal:  Dis Model Mech       Date:  2014-08       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.